Catherine Chai-zon Lee

Board Director

Vice-Président Exécutif, Conseiller Général et Secrétaire

US·SEC (Form 4)

Metacrine, Inc.TFF Pharmaceuticals, Inc.

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 08 Jul 2024 for TFF Pharmaceuticals, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Catherine Chai-zon Lee: trading record in brief

Catherine Chai-zon Lee (board member) discloses dealings in 2 companies, chiefly Metacrine, Inc. and TFF Pharmaceuticals, Inc. Between 5 May 2021 and 3 July 2024, the trades on record add up to 2 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 8 July 2024: a share grant, in TFF Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.